Literature DB >> 3820193

Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity.

T Pincus, L F Callahan.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3820193

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  53 in total

1.  Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis.

Authors:  T Uhlig; T K Kvien; J L Jensen; T Axéll
Journal:  Ann Rheum Dis       Date:  1999-07       Impact factor: 19.103

Review 2.  [Cortisone therapy today].

Authors:  Hanns Kaiser
Journal:  Wien Klin Wochenschr       Date:  2003-01-31       Impact factor: 1.704

3.  Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis.

Authors:  Young Hee Rho; Cecilia P Chung; Annette Oeser; Joseph F Solus; Tebeb Gebretsadik; Ayumi Shintani; Paolo Raggi; Ginger L Milne; C Michael Stein
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-10       Impact factor: 4.794

Review 4.  [Rheumatoid arthritis and cardiovascular complications].

Authors:  W Seidel; M Hecker; U Wagner; H Häntzschel
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

5.  Improving survival in inflammatory rheumatic diseases: a neglected goal?

Authors:  Theodore Pincus; Allan Gibofsky; J Timothy Harrington
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.592

6.  Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis.

Authors:  Yu Asanuma; Cecilia P Chung; Annette Oeser; Joseph F Solus; Ingrid Avalos; Tebeb Gebretsadik; Ayumi Shintani; Paolo Raggi; Tuulikki Sokka; Theodore Pincus; C Michael Stein
Journal:  Atherosclerosis       Date:  2007-06-14       Impact factor: 5.162

7.  Polymorphism of the beta3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine.

Authors:  J F Muñoz-Valle; M Vázquez-Del Mercado; S Ruiz-Quezada; E Oregón-Romero; R E Navarro-Hernández; J Ramírez-Barragán; G Martínez-Bonilla; G Bernard-Medina; B E Bastidas-Ramírez; B Ruiz-Madrigal; A Panduro
Journal:  Rheumatol Int       Date:  2003-03-12       Impact factor: 2.631

8.  Intestinal permeability and inflammation in patients on NSAIDs.

Authors:  G Sigthorsson; J Tibble; J Hayllar; I Menzies; A Macpherson; R Moots; D Scott; M J Gumpel; I Bjarnason
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

Review 9.  Biologic treatments for systemic rheumatic diseases.

Authors:  Y Shirota; G G Illei; N P Nikolov
Journal:  Oral Dis       Date:  2008-02-14       Impact factor: 3.511

10.  Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.

Authors:  R Roubenoff; R A Roubenoff; J G Cannon; J J Kehayias; H Zhuang; B Dawson-Hughes; C A Dinarello; I H Rosenberg
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.